Posttranslationally Modified Fetuin-A in Urine as a Marker for Renal Dysfunction (Patients With Chronic Kidney Disease - With or Without Kidney Transplantation).
Launched by UNIVERSITY HOSPITAL, MARTIN · Apr 22, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria for patients with kidney transplatation:
- • patient age \> 18 years,
- • primary kidney transplantation;
- • at least 12 months after kidney transplantation;
- • immunosuppression: calcineurin inhibitors, mycophenolic acid analogues and corticosteroids;
- • living donor or donation after brain death (DBD) donor;
- • patient cooperation;
- • regular check-ups in Transplant-Nephrology surgery at University Hospital Martin;
- • provision of a sample of the first-morning urine;
- • signed informed consent.
- Exclusion Criteria with kidney transplatation:
- • • patient age \< 18 years;
- • secondary/tertiary kidney transplantation;
- • kidney transplantation in the last 12 months;
- • absence of ≥1 of the basic immunosuppressants (calcineurin inhibitors, mycophenolic acid analogues and corticosteroids);
- • contaminated sample of the first-morning urine (for example, menstruation);
- • non-provision of a sample of the first-morning urine;
- • disagreement of the patient with the Examination and inclusion in the study.
- Inclusion Criteria for patients without kidney transplatation:
- • patient age \> 18 years,
- • chronic kidney injury or acute kidney injury
- • performed renal biopsy
- • patient cooperation;
- • regular check-ups in Transplant-Nephrology surgery at University Hospital Martin;
- • provision of a sample of the first-morning urine;
- • signed informed consent.
- Exclusion Criteria with kidney transplatation:
- • patient age \< 18 years;
- • absence of renal biopsy or non-represenantative sample of renal biopsy
- • contaminated sample of the first-morning urine (for example, menstruation);
- • non-provision of a sample of the first-morning urine;
- • disagreement of the patient with the Examination and inclusion in the study.
About University Hospital, Martin
University Hospital Martin is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to patient-centered care and cutting-edge medical practices, the hospital collaborates with a diverse array of researchers and healthcare professionals to explore new therapeutic approaches and improve patient outcomes. Its state-of-the-art facilities and multidisciplinary teams enable the rigorous evaluation of novel treatments, contributing to the global body of medical knowledge while enhancing the quality of care provided to the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Martin, , Slovakia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported